Treatment outcomes of definitive chemoradiotherapy for patients with hypopharyngeal cancer

Journal of Radiation Research

Volumn 53, Issue 6, 2012, Pages 906-915

  Nakahara, Rie ^a,b   Kodaira, Takeshi ^a   Furutani, Kazuhisa ^a   Tachibana, Hiroyuki ^a   Tomita, Natsuo ^a   Inokuchi, Haruo ^a   Mizoguchi, Nobutaka ^a   Goto, Yoko ^a   Ito, Yoshiyuki ^b   Naganawa, Shinji ^b  

^a AICHI CANCER CENTER HOSPITAL   (Japan)

^b NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

chemoradiotherapy; hypopharyngeal cancer; laryngeal preservation; local control; survival

Indexed keywords

CHEMORADIOTHERAPY; CHEMOTHERAPY; DIAGNOSIS; DISEASE CONTROL; MULTIVARIANT ANALYSIS;

FOLLOW UP; HYPOPHARYNGEAL CANCER; INDUCTION CHEMOTHERAPY; LARYNGEAL PRESERVATION; LOCAL CONTROL; OVERALL SURVIVAL; PROGRESSION FREE SURVIVAL; SECOND PRIMARY CANCER; SURVIVAL; UNIVARIATE ANALYSIS;

DISEASES;

EID: 84870024546     PISSN: 04493060     EISSN: 13499157     Source Type: Journal    
DOI: 10.1093/jrr/rrs052     Document Type: Article

References (19)

1. Pignon JP, Bourhis J, Domenge C et al. Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data. MACH-NC Collaborative Group. Meta-Analysis of Chemotherapy on Head and Neck Cancer. Lancet 2000; 355:949-55. (Pubitemid 30148259)
2. Adelstein DJ, Li Y, Adams GL et al. An intergroup phase III comparison of standard radiation therapy and two schedules of concurrent chemoradiotherapy in patients with unresectable squamous cell head and neck cancer. J Clin Oncol 2003;21:92-8.
3. Taki S, Homma A, Oridate N et al. Salvage surgery for local recurrence after chemoradiotherapy or radiotherapy in hypopharyngeal cancer patients. Eur Arch Otorhinolaryngol 2010;267:1765-9.
4. Lefebvre JL, Chevalier D, Luboinski B et al. Larynx preservation in pyriform sinus cancer: preliminary results of a European Organization for Research and Treatment of Cancer phase III trial. EORTC Head and Neck Cancer Cooperative Group. J Natl Cancer Inst 1996;88:890-9. (Pubitemid 26230640)
5. American Joint Committee on Cancer: AJCC Cancer Staging Manual. ed Fifth. Philadelphia: Lippincott Williams and Wilkins; 1997.
6. Cancer Therapy Evaluation Program. Common terminology criteria for adverse events version 3.0 (CTCAE). Bethesda: National Cancer Institute, 2003. http://ctep.cancer.gov/forms/ CTCAEv3.pdf.
7. Altundag O, Gullu I, Altundag K et al. Induction chemotherapy with cisplatin and 5-fluorouracil followed by chemoradiotherapy or radiotherapy alone in the treatment of locoregionally advanced resectable cancers of the larynx and hypopharynx: results of single-center study of 45 patients. Head Neck 2005;27:15-21. (Pubitemid 40024084)
8. Lambert L, Fortin B, Soulieres D et al. Organ preservation with concurrent chemoradiation for advanced laryngeal cancer: are we succeeding? Int J Radiat Oncol Biol Phys 2010;76:398-402.
9. Fukada J, Shigematsu N, Takeda A et al. Weekly low-dose docetaxel-based chemoradiotherapy for locally advanced oropharyngeal or hypopharyngeal carcinoma: a retrospective, single-institution study. Int J Radiat Oncol Biol Phys 2010;76:417-24.
10. Mendenhall WM, Parsons JT, Stringer SP et al. Radiotherapy alone or combined with neck dissection for T1-T2 carcinoma of the pyriform sinus: an alternative to conservation surgery. Int J Radiat Oncol Biol Phys 1993;27:1017-27. (Pubitemid 23361579)
11. Nakamura K, Shioyama Y, Kawashima M et al. Multiinstitutional analysis of early squamous cell carcinoma of the hypopharynx treated with radical radiotherapy. Int J Radiat Oncol Biol Phys 2006;65:1045-50.
12. Vandenbrouck C, Eschwege F, De la Rochefordiere A et al. Squamous cell carcinoma of the pyriform sinus: retrospective study of 351 cases treated at the Institut Gustave-Roussy. Head Neck Surg 1987;10:4-13. (Pubitemid 19098975)
13. Chen SW, Yang SN, Liang JA et al. Prognostic impact of tumor volume in patients with stage III-IVA hypopharyngeal cancer without bulky lymph nodes treated with definitive concurrent chemoradiotherapy. Head Neck 2009;31:709-16.
14. Tai SK, Yang MH, Wang LW et al. Chemoradiotherapy laryngeal preservation for advanced hypopharyngeal cancer. Jpn J Clin Oncol 2008;38:521-7.
15. Mekhail TM, Adelstein DJ, Rybicki LA et al. Enteral nutrition during the treatment of head and neck carcinoma: is a percutaneous endoscopic gastrostomy tube preferable to a nasogastric tube? Cancer 2001;91:1785-90. (Pubitemid 32377965)
16. Fuwa N, Shibuya N, Hayashi N et al. Treatment results of alternating chemoradiotherapy for nasopharyngeal cancer using cisplatin and 5-fluorouracil - A phase II study. Oral Oncology 2007;43:948-55. (Pubitemid 47369257)
17. Kohmura T, Hasegawa Y, Matsuura H et al. Clinical analysis of multiple primary malignancies of the hypopharynx and esophagus. Am J Otolaryngol 2001;22:107-10. (Pubitemid 32291448)
18. Morimoto M, Nishiyama K, Nakamura S et al. Significance of endoscopic screening and endoscopic resection for esophageal cancer in patients with hypopharyngeal cancer. Jpn J Clin Oncol 2010;40:938-43.
19. Muto M, Minashi K, Yano T et al. Early detection of superficial squamous cell carcinoma in the head and neck region and esophagus by narrow band imaging: a multicenter randomized controlled trial. J Clin Oncol 2010;28:1566-72.